Olanzapine and Fluoxetine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Olanzapine and Fluoxetine drug offered from Teva Pharmaceuticals USA, Inc.. This Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Olanzapine and Fluoxetine |
| SUBSTANCE NAME: | OLANZAPINE; FLUOXETINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-04-10 |
| END MARKETING DATE: | 0000-00-00 |
Olanzapine and Fluoxetine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olanzapine and Fluoxetine from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3; 25(mg/1; mg/1) |
| START MARKETING DATE: | 2013-04-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-5503_8d284348-2517-4b00-ad85-04e17b9f6995 |
| PRODUCT NDC: | 0093-5503 |
| APPLICATION NUMBER: | ANDA202074 |
Other OLANZAPINE; FLUOXETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
